EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor
CHEBI:CHEBI_50390
Definition
An EC 1.6.5.* (oxidoreductase acting on NADH or NADPH with a quinone or similar as acceptor) inhibitor that interferes with the action of NAD(P)H dehydrogenase (quinone), EC 1.6.5.2.
Alternative Names
- dehydrogenase, reduced nicotinamide adenine dinucleotide (phosphate, quinone) inhibitor
- dehydrogenase, reduced nicotinamide adenine dinucleotide (phosphate, quinone) inhibitors
- diaphorase inhibitor
- diaphorase inhibitors
- DT diaphorase inhibitor
- EC 1.6.5.2 (NAD(P)H dehydrogenase (quinone)) inhibitor
- EC 1.6.5.2 (NAD(P)H dehydrogenase (quinone)) inhibitors
- EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitors
- EC 1.6.5.2 inhibitor
- EC 1.6.5.2 inhibitors
- flavoprotein NAD(P)H-quinone reductase inhibitor
- flavoprotein NAD(P)H-quinone reductase inhibitors
- menadione oxidoreductase inhibitor
- menadione oxidoreductase inhibitors
- menadione reductase inhibitor
- menadione reductase inhibitors
- NAD(P)H dehydrogenase (quinone) (EC 1.6.5.2) inhibitor
- NAD(P)H dehydrogenase (quinone) (EC 1.6.5.2) inhibitors
- NAD(P)H dehydrogenase (quinone) inhibitor
- NAD(P)H dehydrogenase (quinone) inhibitors
- NAD(P)H dehydrogenase inhibitor
- NAD(P)H dehydrogenase inhibitors
- NAD(P)H menadione reductase inhibitor
- NAD(P)H menadione reductase inhibitors
- NAD(P)H-quinone dehydrogenase inhibitor
- NAD(P)H-quinone dehydrogenase inhibitors
- NAD(P)H-quinone oxidoreductase inhibitor
- NAD(P)H-quinone oxidoreductase inhibitors
- NAD(P)H: menadione oxidoreductase inhibitor
- NAD(P)H: menadione oxidoreductase inhibitors
- NAD(P)H:(quinone-acceptor)oxidoreductase inhibitor
- NAD(P)H:(quinone-acceptor)oxidoreductase inhibitors
- NAD(P)H:quinone oxidoreductase inhibitor
- NAD(P)H:quinone oxidoreductase inhibitors
- NAD(P)H2 dehydrogenase (quinone) inhibitor
- NAD(P)H2 dehydrogenase (quinone) inhibitors
- NADH-menadione reductase inhibitor
- NADH-menadione reductase inhibitors
- naphthoquinone reductase inhibitor
- naphthoquinone reductase inhibitors
- NQO1 inhibitor
- NQO1 inhibitors
- p-benzoquinone reductase inhibitor
- p-benzoquinone reductase inhibitors
- phylloquinone reductase inhibitor
- phylloquinone reductase inhibitors
- QR1 inhibitor
- QR1 inhibitors
- quinone reductase inhibitor
- quinone reductase inhibitors
- reduced NAD(P)H dehydrogenase inhibitor
- reduced NAD(P)H dehydrogenase inhibitors
- reduced nicotinamide-adenine dinucleotide (phosphate) dehydrogenase inhibitor
- reduced nicotinamide-adenine dinucleotide (phosphate) dehydrogenase inhibitors
- viologen accepting pyridine nucleotide oxidoreductase inhibitor
- viologen accepting pyridine nucleotide oxidoreductase inhibitors
- vitamin K reductase inhibitor
- vitamin K reductase inhibitors
- vitamin-K reductase inhibitor
- vitamin-K reductase inhibitors
Drug Classification
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:50390
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- oboInOwl#id
- CHEBI:50390
- core#notation
- CHEBI:50390
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_53766
- owl#someValuesFrom
- t245336
- owl#annotatedSource
- t235333